CNS Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $8.6M
Liabilities Breakdown FY2025
Total Liabilities: $4.1M
Asset Breakdown
Total Assets: $8.6M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $7.2M | 83.5% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $17.7K | 0.2% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $1.4M | 16.3% |
Liabilities Breakdown
Total Liabilities: $4.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $0 | 0.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $4.1M | 100.0% |